| First Author | Lambracht-Washington D | Year | 2015 |
| Journal | J Neuroimmunol | Volume | 278 |
| Pages | 90-9 | PubMed ID | 25595257 |
| Mgi Jnum | J:350769 | Mgi Id | MGI:7664206 |
| Doi | 10.1016/j.jneuroim.2014.12.007 | Citation | Lambracht-Washington D, et al. (2015) Co-stimulation with TNF receptor superfamily 4/25 antibodies enhances in-vivo expansion of CD4+CD25+Foxp3+ T cells (Tregs) in a mouse study for active DNA Abeta42 immunotherapy. J Neuroimmunol 278:90-9 |
| abstractText | The study was designed to test DNA Abeta42 immunization in mice as alternative approach for possible active immunotherapy in Alzheimer patients. As results, we found polarized Th2 immune responses, efficient Abeta42 antibody levels, and disappearance of antigen specific T cells. In-vivo TNFRSF4/25 antibody co-stimulation enhanced Abeta42 specific T cell responses with initial Th2 expansion and subsequent development of Abeta42 specific CD4+CD25+Foxp3+ cells. It showed that Th2 biased responses due to gene gun immunizations propagate the development of regulatory T cells. In conclusion, full-length DNA Abeta42 immunization into skin results in a regulatory response with minimal risk of inflammation and autoimmunity. |
